Emergence of extended-spectrum β-lactamase-producing Escherichia coli in community hospitals throughout North Carolina: A harbinger of a wider problem in the United States?

Clinical Infectious Diseases

Volumn 49, Issue 2, 2009, Pages

  Freeman, Joshua T ^a   Sexton, Daniel J ^a   Anderson, Deverick J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE;

ARTICLE; COMMUNITY HOSPITAL; ESCHERICHIA COLI; HUMAN; INFORMATION PROCESSING; KLEBSIELLA PNEUMONIAE; PRIORITY JOURNAL; UNITED STATES; URINARY TRACT INFECTION;

ADULT; BETA-LACTAMASES; COMMUNITY-ACQUIRED INFECTIONS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HOSPITALS, COMMUNITY; HUMANS; INCIDENCE; NORTH CAROLINA; UROLOGIC NEOPLASMS; YOUNG ADULT;

EID: 67651124629     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/600046     Document Type: Article

References (13)

1. Woodford N, Ward M, Kaufmann M, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta- lactamases in the UK. J Antimicrob Chemother 2004; 54:735-43.
2. Kassis-Chikhani N, Vimont S, Asselat K, et al. CTX-M beta-lactamase- producing Escherichia coli in long term care facilities, France. Emerg Infect Dis 2004; 10:1697-8.
3. Oteo J, Navarro C, Cercenado E, et al. Spread of Escherichia coli strains with high level cefotaxime and ceftazidime resistance between the community, long term care facilities, and hospital institutions. J Clin Mi- crobiol 2006; 44:2359-66.
4. Ben-ami R, Schwaber M, Navon-Venezia S, et al. Influx of extended- spectrum beta-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 2006;42:925-34.
5. Pitout J, Nordmann P, Laupland K, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005;56:52-9.
6. Canton R, Coque T. The CTX-M b-lactamase pandemic. Curr Opin Microbiol 2006; 9:466-75.
7. Rodriguez-Bano J, Paterson D L. A change in the epidemiology of infections due to extended-spectrum b-lactamase-producing organisms. Clin Infect Dis 2006; 42:935-7.
8. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-85.
9. Klevens R, Morrison M, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298: 1763-71.
10. Pallecchi L, Bartolini A, Fiorelli C, et al. Rapid dissemination and diversity of CTX-M extended-spectrum beta-lactamase genes in commensal Escherichia coli isolates from healthy children from lowresource settings in Latin America. Antimicrob Agents Chemother 2007;51: 2720-5.
11. Brinas L, Moreno M, Zarazaga M, et al. Detection of CMY-2, CTX- M-14 and SHV-12 b-lactamases in Escherichia coli fecal sample isolates from healthy chickens. Antimicrob Agents Chemother 2003; 47:2056-8.
12. Moland E, Black J, Hossain A, et al. DiscoveryofCTX-M-like extended- spectrum b-lactamases in Escherichia coli from five U.S. states. Anti-microb Agents Chemother 2003; 47:2382-3.
13. Lewis J, Herrera M, Wickes B, Patterson J, Jorgensen H. First report of the emergence of CTX-M-type extended-spectrum beta lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob Agents Chemother 2007;51:4015-21.